A Single Group Study to Evaluate the Effects of a Boric Acid Suppository on Vaginal Health.

Love Wellness

Status: Completed

Conditions: Bacterial Vaginosis; Vaginal Health

Treatments: Dietary Supplement: Boric Acid Suppository

Study type: Interventional

Funder types: Industry

Identifiers

NCT06516757

20412

Details and patient eligibility

About

This is a virtual single-group clinical trial that will last 12 weeks. Participants will use The Killer® (Boric Acid Suppositories) once daily for 7 consecutive days when they feel that they are experiencing any of the common signs of vaginal imbalance like vaginal malodor, vaginal irritation, and/or vaginal itching. Participants will complete a questionnaire before using the product and on Days 3 and 7 of using the product. They will also complete a vaginal swab pH test before using the product and after 7 days of using the product (Day 8).

Enrollment: 40 patients

Sex: Female

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Female at birth
• Aged 18+
• Interested in maintaining a calm, soothed, and healthy vaginal environment and balanced vaginal pH levels
• Regularly experience atypical vaginal smell, discharge, itching, swelling, irritation, pain or - burning during sex, and/or a burning sensation while urinating
• Willing to avoid introducing any products or new forms of prescription medication or supplements targeting vaginal health during the study period
• Has used a boric acid suppository before
• Willing to avoid the use of any intra-vaginal products during the study product use
• Willing and able to follow the study protocol

Exclusion criteria

• Surgeries or invasive treatments in the last six months or planned during the study period
• Introduced any products or forms of prescription medication or supplements targeting vaginal health in the last 12 weeks
• Known allergies to the product ingredients
• Diagnosed with chronic health conditions impacting participation
• Pregnant, breastfeeding, or trying to conceive
• History of substance abuse
• Current or former smoker within the past six months
• Unwilling to follow the study protocol
• Currently participating in any other clinical trial or perception study

Trial design

Primary purpose: Supportive Care

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

40 participants in 1 patient group

Boric Acid Suppository Group

Experimental group

Description:

Participants will use 600 mg Boric Acid Gelatin Capsules (The Killer®) once daily for 7 consecutive days when they feel they are experiencing any signs of vaginal imbalance such as vaginal malodor, irritation, and/or itching.

Treatment:

Dietary Supplement: Boric Acid Suppository